fluorodeoxyglucose f18 has been researched along with Elephantiasis Neuromatosis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Ikuta, K; Imagama, S; Ito, K; Ito, S; Koike, H; Nishida, Y; Sakai, T; Urakawa, H | 1 |
| Amann, G; Aszmann, O; Azizi, AA; Benkoe, TM; Hacker, M; Happak, W; Hojreh, A; Kasprian, G; Peyrl, A; Rausch, I; Slavc, I; Staudenherz, A; Theisen, BE; Traub-Weidinger, T; Wadsak, W; Weber, M | 1 |
| Howman-Giles, R; London, K; Moharir, M; North, K | 1 |
| Amrami, KK; Esther, RJ; Lowe, VJ; Shahid, KR; Spinner, RJ | 1 |
| Drubach, L; Fahey, F; Irons, M; Tsai, LL; Ullrich, NJ; Voss, S | 1 |
| Baldwin, A; Derdak, J; Dombi, E; Gillespie, A; Kurwa, A; Meany, H; Reynolds, J; Salzer, W; Tsokos, M; Whatley, M; Widemann, B | 1 |
| Derlin, T; Friedrich, RE; Gawad, K; Hagel, C; Zustin, J | 1 |
| Calonje, E; Ferner, RE; Golding, JF; Jan, W; O'Doherty, M; Sanjayanathan, V; Smith, M | 1 |
| Alavi, A; Basu, S; Cnaan, A; Dombi, E; Fisher, MJ; Phillips, PC; Pollock, AN; Widemann, BC; Yu, JQ; Zhuang, H | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and Elephantiasis Neuromatosis
| Article | Year |
|---|---|
Monitoring of plexiform neurofibroma in children and adolescents with neurofibromatosis type 1 by [
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography | 2018 |
8 other study(ies) available for fluorodeoxyglucose f18 and Elephantiasis Neuromatosis
| Article | Year |
|---|---|
Limitations and benefits of FDG-PET/CT in NF1 patients with nerve sheath tumors: A cross-sectional/longitudinal study.
Topics: Adolescent; Adult; Aged; Carcinogenesis; Child; Cross-Sectional Studies; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; ROC Curve; Young Adult | 2021 |
Utility of positron emission tomography for tumour surveillance in children with neurofibromatosis type 1.
Topics: Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Neurofibroma, Plexiform; Neurofibromatosis 1; Optic Nerve Glioma; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
False-negative fluorine-18 fluorodeoxyglucose positron emission tomography of a malignant peripheral nerve sheath tumor arising from a plexiform neurofibroma in the setting of neurofibromatosis type 1.
Topics: Adult; Diagnosis, Differential; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
[18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation.
Topics: Adolescent; Adult; Cell Transformation, Neoplastic; Child; Child, Preschool; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2012 |
18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST).
Topics: Adolescent; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Surgery for atypical plexiform neurofibromas of the trunk in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin: a long-term follow-up.
Topics: Biomarkers, Tumor; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ki-67 Antigen; Membrane Glycoproteins; Mucin-1; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; S100 Proteins; Young Adult | 2012 |
[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
Topics: Adolescent; Adult; Age Factors; Aged; Biopsy, Needle; Child; Child, Preschool; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Probability; Risk Assessment; Sensitivity and Specificity; Sex Factors; Tomography, X-Ray Computed | 2008 |
The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progression.
Topics: Adolescent; Adult; Child; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Neurofibroma, Plexiform; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2008 |